Note: Ingredients listed on restricted chemical lists
EC/CAS
138-86-3
Name of the chemical
1-methyl-4-prop-1-en-2-yl-cyclohexene; dl-limonene (racemic); Dipentene (37) (R)-p-mentha-1,8-diene; (d-limonene) (S)-p-mentha-1,8-diene; (l-limonene) (37)
Concentration
100%
General Information
Version
1.0
Revision date
2013-03-10
Product name
DL-Limonene (mixture of D- and L-form ~1:1) for synthesis
1.2.1 Relevant identified uses
Chemical for synthesis
Emergency telephone
800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
EMD Millipore Corporation
e-mail address of the competent person responsible for the Safety Data Sheet
mm_sds@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H226, H315, H317, H400, H410
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
H315
Causes skin irritation
H317
May cause an allergic skin reaction
H400
Very toxic to aquatic life
H410
Very toxic to aquatic life with long lasting effects
Section 2
SECTION 2: Hazards identification
OSHA Hazards GHS Classification Flammable liquid, Category 3, H226 Skin irritation, Category 2, H315 Skin sensitization, Category 1, H317 Acute aquatic toxicity, Category 1, H400 Chronic aquatic toxicity, Category 1, H410 For the full text of the H-Statements mentioned in this Section, see Section 16
Signal word
Warning
Hazard statements
H226 Flammable liquid and vapor. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H410 Very toxic to aquatic life with long lasting effects.
Precautionary statements
P210 Keep away from heat. P273 Avoid release to the environment. P280 Wear protective gloves. P302 + P352 IF ON SKIN: Wash with plenty of soap and water.
2.3 Other hazards
None known.
2.1 Classification of the substance or mixture
Flammable liquid, Category 3, H226 Skin irritation, Category 2, H315 Skin sensitization, Category 1, H317 Acute aquatic toxicity, Category 1, H400 Chronic aquatic toxicity, Category 1, H410 For the full text of the H-Statements mentioned in this Section, see Section 16.